We are live on
!
Find out more
BFC
Blue Fin Capital Portfolio holdings
AUM
$692M
1-Year Est. Return
27.29%
This Fund
S&P 500
This Quarter
Est. Return
+5.04%
1 Year Est. Return
+27.29%
3 Year Est. Return
+125.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+590.83%
AUM
$125M
AUM Growth
+$11.3M
(+9.9%)
Cap. Flow
+$5.85M
Cap. Flow
% of AUM
4.69%
Top 10 Holdings %
Top 10 Hldgs %
31.83%
Holding
131
New
12
Increased
58
Reduced
39
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Senior Loan ETF
BKLN
|
+$503K |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$356K |
| 3 |
Accenture
ACN
|
+$331K |
| 4 |
Sturm, Ruger & Co
RGR
|
+$266K |
| 5 |
Qualcomm
QCOM
|
+$247K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$224K |
| 2 |
Southern Copper
SCCO
|
+$212K |
| 3 |
Rayonier
RYN
|
+$206K |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$118K |
| 5 |
iShares Russell 3000 ETF
IWV
|
+$98.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.56% |
| 2 | Healthcare | 11.23% |
| 3 | Financials | 10.05% |
| 4 | Energy | 9.77% |
| 5 | Consumer Staples | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Suncor Energy
SU
$76.1B
| $202K | 0.16% |
+4,750
| New | +$185K |
|
|
COV
127
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $201K | 0.16% |
+2,230
| New | +$167K |
|
128
PetMed Express
PETS
$42.5M
| $144K | 0.12% |
+10,715
| New | +$141K |
|
|
RAD
129
DELISTED
Rite Aid Corporation
RAD
| $119K | 0.1% |
+830
| New | +$123K |
|
|
130
Boston Scientific
BSX
$71.1B
| – | – |
-16,600
| Closed | -$224K |
|
|
131
Southern Copper
SCCO
$163B
| – | – |
-7,854
| Closed | -$212K |
|
Similar funds
CL
CPA
NMC
SSA
WC
CGIC
LCP
SAM
Blue Fin Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Blue Fin Capital held 131 positions worth $125M, up 9.9% from $113M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Blue Fin Capital deployed $5.85M of net new capital in Q2 2014, opening 12 new positions and adding to 58 existing holdings. Its largest new stake was Accenture: 4,125 shares worth $333K.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Rayonier, an estimated $206K trimmed.
- Blue Fin Capital's largest Q2 2014 buy was Accenture: 4,125 shares worth $333K.
- Blue Fin Capital added most to Invesco Senior Loan ETF in Q2 2014, an estimated $503K increase.
- Blue Fin Capital's biggest Q2 2014 reduction was Rayonier, cutting an estimated $206K.
- Blue Fin Capital fully exited Boston Scientific in Q2 2014, selling an estimated $224K.
- Blue Fin Capital's ten largest holdings make up 32% of its $125M portfolio in Q2 2014.
- Blue Fin Capital opened 12 new positions and closed 2 in Q2 2014.
- Blue Fin Capital's portfolio value rose 9.9% quarter-over-quarter to $125M.
Based on Blue Fin Capital's 13F filing for Q2 2014, filed 29 Jul 2014.